Writing, thinking and senior woman at a house making notes on notebook paper. Retirement of a serious person from Sweden think about schedule, day agenda idea or document and write ideas at home

(© K Abrahams/peopleimages.com - stock.adobe.com)

In A Nutshell

  • People with none of three midlife health risks (diabetes, high blood pressure, smoking) averaged 12.6 more dementia-free years than those with all three, according to a study of 12,409 people followed for a median of 26 years.
  • Dementia-free years dropped steadily with each added risk factor: 30.1 years with zero, down to 17.5 years with all three.
  • People with all three risk factors were far more likely to die of other causes before dementia ever developed, which is why their lifetime dementia rate ended up lower by age 95 despite their higher overall risk.
  • Women, white participants, and people without the APOE-ε4 gene variant all had more dementia-free years on average, though the same risk pattern held true across every group.

Staying clear of diabetes, high blood pressure, and smoking through middle age may promote more than a decade of extra dementia-free years compared to peers carrying all three conditions. A large, long-running community-based study published in Neurology® Open Access and tracking 12,409 participants from four U.S. communities found that the gap in dementia-free years between the healthiest and least healthy midlife groups was 12.6 years, a number researchers say offers a clear, personal way to think about heart health and brain aging.

Dementia already looms large over American life. Roughly 42% of middle-aged adults in the U.S. may develop the condition during their lifetime, according to prior research cited in the study. Most conversations about preventing it focus on the odds of getting it at all, rather than something more personal: how many good cognitive years a person actually gets to enjoy. This study set out to answer that second question directly.

Researchers Followed 12,000 People for Nearly 30 Years

Researchers drew on data from the Atherosclerosis Risk in Communities study, a long-running project that began enrolling participants between 1987 and 1989 across four U.S. locations: Forsyth County, North Carolina; Jackson, Mississippi; the Minneapolis suburbs; and Washington County, Maryland. The team focused on 12,409 participants who were alive and free of dementia at age 55, with an average starting age of about 56. Just over half were women.

At a baseline checkup in the early 1990s, researchers noted whether each participant had diabetes, high blood pressure, or was a current smoker, then gave everyone a simple score from zero to three based on how many of those three conditions applied. From there, participants were tracked for a median of about 26 years, in some cases all the way to 2022. Over that stretch, 3,008 people developed dementia and 5,238 died without ever developing it.

Doctors did not rely on guesswork to identify dementia cases. Participants took cognitive tests in person, completed phone interviews when they could not make it to a visit, and had their hospital and death records checked continuously. An expert panel confirmed every diagnosis.

Businessman smoking a cigarette
Avoiding three common midlife health risks may buy 12.6 more years of life without dementia, new research shows. (Photo creidt: © Alem Bradic | Dreamstime.com)

The More Risk Factors, the Fewer Good Years

A clear step-down pattern emerged. People with none of the three risk factors averaged 30.1 dementia-free years between ages 55 and 95. Add one risk factor and that number dropped to 26.3. Two dropped it to 21.0. All three brought it down to 17.5, a 12.6-year difference from the healthiest group. Only 176 participants landed in that highest-risk group, a small enough sample that the exact number carries more uncertainty than the figures for the larger groups.

Here is the twist: people with all three risk factors were nearly three times as likely to develop dementia as those with none, but they were more than five times as likely to die of something else first, before dementia ever got the chance to set in. By age 75, 10% of the highest-risk group had developed dementia, compared to just 3% of the healthiest group. By age 95, those numbers had essentially flipped, with the healthiest group reaching a 42% dementia rate while the highest-risk group topped out at just 23%. That is not because bad health protects against dementia. It is because the unhealthiest participants were, tragically, dying earlier from other causes.

Race and Sex Gaps in Dementia-Free Years Are Real

More risk factors meant fewer good years for every group researchers looked at, though the numbers were not identical across the board.

Women outlived men in dementia-free years at every risk level, averaging 18.1 years versus 16.6 for men among those with all three conditions. Women also had a higher lifetime rate of dementia by age 95, 40.3% compared to 32.8% for men, likely simply because they tend to live longer, giving the disease more years in which to appear.

Black participants had shorter dementia-free years than white participants at every risk level too. Among those with all three conditions, Black participants averaged 16.0 dementia-free years compared to 19.6 for white participants. Black participants also made up 60.2% of the highest-risk group despite representing a smaller share of the overall study population. Researchers say that heavier burden of health risk likely contributes to the disparity, and that addressing the social and economic forces behind it will matter just as much as clinical treatment.

People carrying a gene variant called APOE-ε4, which is linked to higher dementia risk, had fewer dementia-free years than non-carriers at every single risk level, from zero risk factors up through all three.

Heart Health in Midlife Buys More Years With a Clear Mind

Once someone developed dementia, survival afterward was short, typically between 3 and 4 years regardless of their earlier risk profile. People with more vascular risk factors also spent a larger share of their remaining lifespan living with the disease.

Dodging a heart attack or stroke is only part of the beneficial picture. Keeping blood pressure, blood sugar, and smoking habits in check in midlife appears to buy something harder to put a price on: years spent with a clear mind. Turning an abstract risk percentage into a real number of years lived intact gives people, and their doctors, a much sharper reason to take those numbers seriously well before old age arrives.


Disclaimer: This article summarizes findings from a single observational study and is intended for general informational purposes. It is not medical advice. Individual risk depends on many personal factors, and anyone with questions about diabetes, blood pressure, smoking, or dementia risk should speak with a qualified healthcare provider.


Paper Notes

Limitations

Researchers measured vascular risk factors at a single point in midlife, meaning changes in health status over time were not captured. This approach could underestimate the total impact of sustained or worsening risk factors. Dementia detection may have differed between participants who attended in-person study visits and those assessed remotely by phone, potentially affecting diagnostic accuracy across the cohort. There was also a slight timing mismatch between when some covariates were measured and the study’s starting age of 55. As with all observational research, the possibility of residual confounding, hidden factors influencing the results, cannot be completely eliminated.

Funding and Disclosures

This study was supported by the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute grant K24 HL152440; NIH/National Institute of Diabetes and Digestive and Kidney Diseases grant K01 DK138273; the National Institute of Neurological Disorders and Stroke Intramural Research Program; and the National Natural Science Foundation of China (72504161). The ARIC study is supported by NHLBI contracts 75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004, and 75N92022D00005. The ARIC Neurocognitive Study is supported by grants U01HL096812, U01HL096814, U01HL096899, U01HL096902, and U01HL096917. The funders had no role in study design, data collection, analysis, or the decision to publish. The authors reported no relevant disclosures. The Article Processing Charge was funded by the authors.

Publication Details

Authors: Jiaqi Hu, Josef Coresh, Jason R. Smith, A. Richey Sharrett, Rebecca F. Gottesman, Pamela L. Lutsey, Thomas H. Mosley, Elizabeth Selvin, Michael Fang, and Jordan Weiss. | Institutional affiliations include: Tsinghua University (Beijing, China); NYU Grossman School of Medicine (New York, NY); University of North Carolina School of Medicine (Chapel Hill); Johns Hopkins Bloomberg School of Public Health (Baltimore, MD); Johns Hopkins Welch Center (Baltimore, MD); National Institute of Neurological Disorders and Stroke (Bethesda, MD); University of Minnesota School of Public Health (Minneapolis); University of Mississippi School of Medicine (Jackson, MS). | Journal: Neurology® Open Access, Volume 2, Number 3, September 2026. | Paper title: “Midlife Vascular Risk Burden and Dementia-Free Survival Years: The Atherosclerosis Risk in Communities Neurocognitive Study.” | DOI: 10.1212/WN9.0000000000000152

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor